Journal Home
Search for

Volume 75, Issue 1, Pages 42-46 (January 2007)


View previous. 8 of 22 View next.

Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy

Lucrecia HerranzCorresponding Author Informationemail address, Luis F. Pallardo, Natalia Hillman, Pilar Martin-Vaquero, Africa Villarroel, Alberto Fernandez

Received 2 January 2006; accepted 31 May 2006. published online 13 July 2006.

Abstract 

Objective

To determine which maternal glycaemic parameters in type 1 diabetes better predict large-for-gestational-age (LGA) infants.

Methods

Maternal glycaemic parameters (mean overall, preprandial, and postprandial glucose; the percentage of glucose readings above and below target and HbA1c levels) of LGA (n=37) and appropriate-for-gestational-age (n=36) infants were compared during preconception and each trimester of pregnancy. Logistic regression was used to select predictive variables.

Results

Preconception glycaemic parameters were not different. Mean glucose and the percentage of glucose readings above target were higher in mothers of LGA infants in every trimester of pregnancy. Second and third trimesters mean postprandial glucose, third trimester mean preprandial glucose and third trimester HbA1c were also higher. Only third trimester glycaemic variables were risk indicators of LGA infants: mean glucose (OR: 3.45; 95% CI: 1.52–7.80), mean preprandial glucose (OR: 2.97; 95% CI: 1.34–6.60), mean postprandial glucose (OR: 2.09; 95% CI: 1.19–3.67) and the percentage of glucose readings above target (OR: 1.08; 95% CI: 1.03–1.14). The percentage of glucose readings above target was the best risk indicator.

Conclusions

Third trimester glycaemic parameters are more powerful predictors of foetal growth than glycaemic parameters earlier in pregnancy or during preconception. Hyperglycaemic excursions are the strongest predictor of LGA infants.

Division of Diabetes, Department of Endocrinology, Hospital Universitario La Paz, Madrid, Spain

Corresponding Author InformationCorresponding author at: Unidad de Diabetes, Hospital Universitario La Paz, Paseo de la Catellana 261, 28046 Madrid, Spain. Tel.: +34 91 7277100; fax: +34 91 3581185.

PII: S0168-8227(06)00236-1

doi:10.1016/j.diabres.2006.05.019


View previous. 8 of 22 View next.